MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice

Calcified Tissue International

Volumn 89, Issue 3, 2011, Pages 221-227

  Conradie, Maria M ^a   Cato, Andrew C B ^b   Ferris, William F ^a   De Wet, Heidi ^a   Horsch, Kay ^a   Hough, Stephen ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

ERK; Glucocorticoid; MKP 1; Osteoblast; Osteoporosis

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN TYROSINE PHOSPHATASE; SOLIMEDROL; UNCLASSIFIED DRUG; VANADIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE MINERALIZATION; BONE STRENGTH; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; HOMOZYGOSITY; IN VIVO STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE DENSITY; BONE DISEASES; DRUG RESISTANCE; DUAL SPECIFICITY PHOSPHATASE 1; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; MALE; METHYLPREDNISOLONE; MICE; MICE, KNOCKOUT; OSTEOGENESIS;

EID: 80052726002     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9509-x     Document Type: Article

References (46)

1. E Canalis G Mazziotti A Giustina JP Bilezekian 2007 Glucocorticoid- induced osteoporosis: pathophysiology and therapy Osteoporos Int 18 1319 1328 17566815 10.1007/s00198-007-0394-0 1:CAS:528:DC%2BD2sXhtVagurrN (Pubitemid 47389469)
2. Weinstein RS (2008) Glucocorticoid-induced osteoporosis. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edn. ASBMR, Washington, pp 267-272
3. SC Manolagas 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocr Rev 21 115 137 10782361 10.1210/er.21.2.115 1:STN:280: DC%2BD3c3ksVaiug%3D%3D (Pubitemid 32275592)
4. CA O'Brien D Jia LI Plotkin T Bellido CC Powers SA Stewart SC Manolagas RS Weinstein 2004 Glucocorticoids act directly on osteoblasts and osteocytes to induces their apoptosis and reduce bone formation and strength Endocrinology 145 1835 1841 14691012 10.1210/en.2003-0990 (Pubitemid 38402392)
5. Y Engelbrecht H de Wet K Horsch CR Langeveldt FS Hough A Hulley 2003 Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines Endocrinology 144 412 422 12538600 10.1210/en.2002-220769 1:CAS:528:DC%2BD3sXhtVWlsbk%3D (Pubitemid 36205211)
6. K Horsch H de Wet MM Schuurmans F Allie-Reid AC Cato J Cunningham JM Burrin FS Hough PA Hulley 2007 Mitogen-activated protein kinase phosphatase-1/dual specificity phosphatase-1 mediates glucocorticoid inhibition of osteoblast proliferation Mol Endocrinol 21 2929 2940 17761948 10.1210/me.2007-0153 1:CAS:528:DC%2BD2sXhsVeit7nF (Pubitemid 350225576)
7. PA Hulley F Gordon FS Hough 1998 Inhibition of MAPK activity and proliferation of an early osteoblast cell line (MBA-15.4) by dexamethasone: role of protein phosphatases Endocrinology 139 2423 2431 9564854 10.1210/en.139.5.2423 1:CAS:528:DyaK1cXivFShu7k%3D (Pubitemid 28513768)
8. PA Hulley MM Conradie CR Langeveldt FS Hough 2002 Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate Bone 31 220 229 12110438 10.1016/S8756-3282(02)00807-4 1:CAS:528:DC%2BD38XltFWgs7o%3D (Pubitemid 34754451)
9. MM Conradie H de Wet DD Kotze JM Burrin FS Hough PA Hulley 2007 Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo J Endocrinol 195 229 240 17951534 10.1677/JOE-07-0217 1:CAS:528:DC%2BD2sXhtlGms73I (Pubitemid 350143103)
10. T Boutros E Chevet P Metrakos 2008 Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death and cancer Pharmacol Rev 60 261 310 18922965 10.1124/pr.107.00106 1:CAS:528: DC%2BD1MXmsVChtrc%3D
11. KI Patterson T Brummer PM O'Brien RJ Daly 2009 Dual-specificity phosphatases: critical regulators with diverse cellular targets Biochem J 418 475 489 19228121 1:CAS:528:DC%2BD1MXitlWhtbs%3D
12. A Farooq M Zhou 2004 Structure and regulation of MAPK phosphatases Cell Signal 16 769 779 15115656 10.1016/j.cellsig.2003.12.008 1:CAS:528: DC%2BD2cXjs1Wkt7g%3D (Pubitemid 38534526)
13. WJAJ Hendriks A Elson S Harroch AW Stoker 2008 Protein tyrosine phosphatases: functional inferences from mouse models and human disease FEMS J 275 816 830 1:CAS:528:DC%2BD1cXivFaqt7Y%3D (Pubitemid 351230202)
14. JA Goldner 1938 A modification of the Masson trichrome technique for routine laboratory purposes Am J Pathol 14 237 242 19970387 1:STN:280: DC%2BC3critFCrtg%3D%3D
15. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 595 610 3455637 10.1002/jbmr.5650020617 1:STN:280: DyaL1czjvVemsQ%3D%3D
16. A Ogawa JH Johnson M Ohneda CT McAllister L Inman T Alam RH Unger 1992 Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes J Clin Invest 90 497 504 1644920 10.1172/JCI115886 1:CAS:528: DyaK38XlsVersro%3D
17. MA Bogoyevitch NW Court 2004 Counting on mitogen-activated protein kinases-ERKs 3, 4, 5, 6, 7 and 8 Cell Signal 16 1345 1354 15381250 10.1016/j.cellsig.2004.05.004 1:CAS:528:DC%2BD2cXnslentbs%3D (Pubitemid 39277500)
18. LO Murphy J Blenis 2006 MAPK signal specificity: the right place at the right time Trends Biochem Sci 31 268 275 16603362 10.1016/j.tibs.2006.03.009 1:CAS:528:DC%2BD28Xks1ektb8%3D (Pubitemid 43674354)
19. CJ Marshall 1995 Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation Cell 80 179 185 7834738 10.1016/0092-8674(95)90401-8 1:CAS:528:DyaK2MXjtlGnsr8%3D
20. NS Datta GJ Pettway C Chen AJ Koh LK McCauley 2007 Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells J Bone Miner Res 22 7 951 959 17501623 10.1359/jbmr.070328 1:CAS:528: DC%2BD2sXpt1KnsL0%3D (Pubitemid 351339717)
21. G Xiao D Jiang P Thomas MD Benson K Guan G Karsenty RT Franceschi 2000 MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor cbfa1 J Biol Chem 275 6 4453 4459 10660618 10.1074/jbc.275.6.4453 1:CAS:528:DC%2BD3cXht12nsr0%3D (Pubitemid 30094689)
22. RT Franceschi G Xiao D Jiang R Gopalakrishnan S Yang E Reith 2003 Multiple signaling pathways converge on the cbfa1/runx2 transcription factor to regulate osteoblast differentiation Connect Tissue Res 44 109 116 12952183 1:CAS:528:DC%2BD3sXjtlanurk%3D (Pubitemid 36395431)
23. C Ge G Xiao RT Franceschi 2007 Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development J Cell Biol 176 5 709 718 17325210 10.1083/jcb.200610046 1:CAS:528:DC%2BD2sXisVymtbw%3D (Pubitemid 46333984)
24. CA Higuchi N Myoui K Hashimoto K Kuriyama H Yoshioka K Itoh 2002 Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix J Bone Miner Res 17 1785 1794 12369782 10.1359/jbmr.2002.17.10.1785 1:CAS:528: DC%2BD38XnvFyitLg%3D
25. KY Nakayama M Tamura S Suzawa S Harada S Fukumoto M Kato K Miyazono GA Rodan Y Takeuchi T Fujita 2003 Receptor tyrosine kinases inhibit bone morphogenetic protein-smad responsive promoter activity and differentiation of MC3T3-E1 osteoblast like cells J Bone Miner Res 18 827 835 12733721 10.1359/jbmr.2003.18.5.827 1:CAS:528:DC%2BD3sXjslahsro%3D (Pubitemid 37294965)
26. NS Datta C Chen JE Berry LK McCauley 2005 PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest J Bone Miner Res 20 6 1051 1064 15883646 10.1359/JBMR.050106 1:CAS:528:DC%2BD2MXlsFeht70%3D (Pubitemid 40712830)
27. NS Datta R Kolailat A Fite G Pettway AB Abou-Samra 2010 Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation Cell Signal 22 457 466 19892016 10.1016/j.cellsig.2009.10.017 1:CAS:528:DC%2BD1MXhsFGku7fI
28. H Waterman Y Yarden 2001 Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases FEBS Lett 490 142 152 11223029 10.1016/S0014-5793(01)02117-2 1:CAS:528:DC%2BD3MXht1OrtrY%3D (Pubitemid 32171933)
29. E Buck A Eyzaguirre M Rosenfeld-Franklin S Thomson M Mulvihill S Barr E Brown M O'Connor Y Yao J Pachter M Miglarese D Epstein KK Iwata JD Haley NW Gibson QS Ji 2008 Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors Cancer Res 68 20 8322 8332 18922904 10.1158/0008-5472.CAN-07-6720 1:CAS:528:DC%2BD1cXht1Cmsb3M
30. WJ Langlois T Sasaoka AR Saltiel JM Olefsky 1995 Negative feedback regulation and desensitization of insulin and epidermal growth factor-stimulated p21 ras activation J Biol Chem 270 25320 25323 7592690 10.1074/jbc.270.18.10885 1:CAS:528:DyaK2MXovFyltrk%3D
31. S Donovan KM Shannon G Bollag 2002 GTPase activating proteins: critical regulators of intracellular signaling Biochim Biophys Acta 160 23 45 (Pubitemid 34311898)
32. M Camps A Nichols S Arkinstall 2000 Dual specificity phosphatases: a gene family for control of MAP kinase function FASEB J 14 6 16 10627275 1:CAS:528:DC%2BD3cXltFKgtA%3D%3D (Pubitemid 30051518)
33. RJ Dickinson SM Keyse 2006 Diverse physiological functions for dual-specificity MAP kinase phosphatases J Cell Sci 119 4607 4614 17093265 10.1242/jcs.03266 1:CAS:528:DC%2BD2sXktF2m (Pubitemid 44964257)
34. 1 to S phase J Biol Chem 280 4 3104 3111 15513917 10.1074/jbc.M409846200 1:CAS:528:DC%2BD2MXmt12gsA%3D%3D (Pubitemid 40189421)
35. M Homme CP Schmitt O Mehls F Schaefer 2004 Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells J Am Soc Nephrol 15 2844 2850 15504937 10.1097/01.ASN.0000143472.13214.2C (Pubitemid 41103393)
36. TL Aghaloo FQ Pirih A Shi O Bezouglaia S Tetradis 2006 Parathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling Periodontol 77 21 30 10.1902/jop.2006.77.1.21 1:CAS:528:DC%2BD2sXhtVWkur%2FI (Pubitemid 43949653)
37. SM Abraham T Lawrence A Kleiman P Warden M Medghalchi J Tuckermann J Saklatvala AR Clark 2006 Anti-inflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 J Exp Med 203 8 1883 1889 16880258 10.1084/jem.20060336 1:CAS:528:DC%2BD28XotleisL4%3D (Pubitemid 44188463)
38. K Dorfman D Carrasco M Gruda C Ryan SA Lira R Bravo 1996 Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAPkinase activity in ERP/MKP-1 deficient fibroblasts Oncogene 13 5 925 931 8806681 1:CAS:528:DyaK28XmtFans78%3D (Pubitemid 26329078)
39. H Sakaue W Ogawa T Nakamura T Mori K Nakamura M Kasuga 2004 Role of MAPK phosphatase-1 (MKP-1) in adipocyte J Biol Chem 279 38 39951 39957 15269202 10.1074/jbc.M407353200 1:CAS:528:DC%2BD2cXnsVKrsr4%3D (Pubitemid 39258268)
40. M Bazuine F Carlotti RS Tafrechi RC Hoeben JA Maassen 2004 Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes Mol Endocrinol 18 7 1697 1707 15184525 10.1210/me.2003-0213 1:CAS:528: DC%2BD2cXls1aktbs%3D (Pubitemid 38859577)
41. Y Zhou ED Ling ST Dheen 2007 Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia J Neurochem 102 3 667 678 17403137 10.1111/j.1471-4159.2007.04535.x 1:CAS:528:DC%2BD2sXovVyju70%3D (Pubitemid 47057277)
42. R Fürst T Schroeder HM Eilken MF Bubik AK Kiemer S Zahler AM Vollmar 2007 MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in human endothelium FASEB J 21 1 74 80 17099067 10.1096/fj.06-6752com (Pubitemid 46052546)
43. JV Maier S Brema J Tuckermann U Herzer M Klein M Stassen A Moorthy AC Cato 2001 Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids Mol Endocrinol 21 2663 2671 10.1210/me.2007-0067
44. O Kassel A Sancono J Krätzschmar B Kreft M Stassen AC Cato 2001 Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 EMBO J 20 24 7108 7116 11742987 10.1093/emboj/20.24.7108 1:CAS:528:DC%2BD38XpsFOk (Pubitemid 34062302)
45. KV Salojin IB Owusu KA Millerchip M Potter KA Platt T Oravecz 2006 Essential role of MAPK phosphatase-1 in the negative control of innate immune responses J Immunol 176 1899 1907 16424221 1:CAS:528:DC%2BD28XlsFyktw%3D%3D (Pubitemid 43134335)
46. JJ Wu RJ Roth EJ Anderson EG Hong MK Lee CS Choi PD Neufer GI Shulman JK Kim AM Bennett 2006 Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet induced obesity Cell Metab 4 1 61 73 16814733 10.1016/j.cmet.2006.05.010 1:CAS:528:DC%2BD28XmvFyhsr4%3D (Pubitemid 43942257)